|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fisher B, Bauer M, Wickerham DL, Redmond
CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R,
et al: Relation of number of positive axillary nodes to the
prognosis of patients with primary breast cancer. An NSABP update.
Cancer. 52:1551–1557. 1983.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Moore MP and Kinne DW: Axillary
lymphadenectomy: A diagnostic and therapeutic procedure. J Surg
Oncol. 66:2–6. 1997.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jakub JW, Bryant K, Huebner M, Hoskin T,
Boughey JC, Reynolds C and Degnim AC: The number of axillary lymph
nodes involved with metastatic breast cancer does not affect
outcome as long as all disease is confined to the sentinel lymph
nodes. Ann Surg Oncol. 18:86–93. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Galimberti V, Cole BF, Zurrida S, Viale G,
Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, et
al: International Breast Cancer Study Group Trial 23-01
investigators: Axillary dissection versus no axillary dissection in
patients with sentinel-node micrometastases (IBCSG 23-01): A phase
3 randomised controlled trial. Lancet Oncol. 14:297–305.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Reed J, Rosman M, Verbanac KM, Mannie A,
Cheng Z and Tafra L: Prognostic implications of isolated tumor
cells and micrometastases in sentinel nodes of patients with
invasive breast cancer: 10-year analysis of patients enrolled in
the prospective East Carolina University/Anne Arundel Medical
Center Sentinel Node Multicenter Study. J Am Coll Surg.
208:333–340. 2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Carlo JT, Grant MD, Knox SM, Jones RC,
Hamilton CS, Livingston SA and Kuhn JA: Survival analysis following
sentinel lymph node biopsy: A validation trial demonstrating its
accuracy in staging early breast cancer. Proc Bayl Univ Med Cent.
18:103–107. 2005.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Chu PG and Weiss LM: Keratin expression in
human tissues and neoplasms. Histopathology. 40:403–439.
2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tsujimoto M, Nakabayashi K, Yoshidome K,
Kaneko T, Iwase T, Akiyama F, Kato Y, Tsuda H, Ueda S, Sato K, et
al: One-step nucleic acid amplification for intraoperative
detection of lymph node metastasis in breast cancer patients. Clin
Cancer Res. 13:4807–4816. 2007.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li D, Xu X, Chen J, Chen J, Yang B, Yang
W, Xu W, Wu J and Shi D: Utility of one-step nucleic acid
amplification (OSNA) assay in detecting breast cancer metastases of
sentinel lymph nodes in a Chinese population. Breast Cancer.
22:135–140. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leidenius MHK, Krogerus LA, Toivonen TS
and Von Smitten KJ: The feasibility of intraoperative diagnosis of
sentinel lymph node metastases in breast cancer. J Surg Oncol.
84:68–73. 2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Raia-Barjat T, Trombert B, Khaddage A,
Douchet C, Seffert P, Peoc'h M, Falk AT, Magné N and Chauleur C:
OSNA (one-step nucleic acid amplification) sentinel lymph node
intraoperative molecular analysis in breast cancer: A cost-benefit
analysis. Med Oncol. 31(322)2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Castellano I, Macrì L, Deambrogio C,
Balmativola D, Bussone R, Ala A, Coluccia C and Sapino A:
Reliability of whole sentinel lymph node analysis by one-step
nucleic acid amplification for intraoperative diagnosis of breast
cancer metastases. Ann Surg. 255:334–342. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Saruta Y and Puig-Junoy J: Cost and budget
impact analysis of an accurate intraoperative sentinel lymph node
diagnosis for breast cancer metastasis. Appl Health Econ Health
Policy. 14:323–335. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Klingler S, Marchal F, Rauch P, Kenouchi
O, Chrétien AS, Genin P, Leroux A and Merlin JL: Using one-step
nucleic acid amplification (OSNA) for intraoperative detection of
lymph node metastasis in breast cancer patients avoids second
surgery and accelerates initiation of adjuvant therapy. Ann Oncol.
24:2305–2309. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Giuliano AE, Ballman KV, McCall L, Beitsch
PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW,
Blumencranz PW, et al: Effect of axillary dissection vs no axillary
dissection on 10-year overall survival among women with invasive
breast cancer and sentinel node metastasis: The ACOSOG Z0011
(Alliance) Randomized Clinical Trial. JAMA. 318:918–926.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Donker M, van Tienhoven G, Straver ME,
Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH,
Klinkenbijl JH, Orzalesi L, et al: Radiotherapy or surgery of the
axilla after a positive sentinel node in breast cancer (EORTC
10981-22023 AMAROS): A randomised, multicentre, open-label, phase 3
non-inferiority trial. Lancet Oncol. 15:1303–1310. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sobin LH and Wittekind CH (eds): UICC: TNM
Classification of Malignant Tumors. 6th edition. Wiley-Liss, New
York, NY, 2002.
|
|
19
|
Sauerbrei W and Schumacher M: A bootstrap
resampling procedure for model building: Application to the Cox
regression model. Stat Med. 11:2093–2109. 1992.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Terrenato I, D'Alicandro V, Casini B,
Perracchio L, Rollo F, De Salvo L, Di Filippo S, Di Filippo F,
Pescarmona E, Maugeri-Saccà M, et al: A cut-off of 2150 cytokeratin
19 mRNA copy number in sentinel lymph node may be a powerful
predictor of non-sentinel lymph node status in breast cancer
patients. PLoS One. 12(e0171517)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tamaki Y: One-step nucleic acid
amplification (OSNA): Where do we go with it? Int J Clin Oncol.
22:3–10. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Snook KL, Layer GT, Jackson PA, de Vries
CS, Shousha S, Sinnett HD, Nigar E, Singhal H, Chia Y, Cunnick G,
et al: OSNA Study Group: Multicentre evaluation of intraoperative
molecular analysis of sentinel lymph nodes in breast carcinoma. Br
J Surg. 98:527–535. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Cserni G: Intraoperative analysis of
sentinel lymph nodes in breast cancer by one-step nucleic acid
amplification. J Clin Pathol. 65:193–199. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shi F, Liang Z, Zhang Q, Wang C and Liu X:
The performance of one-step nucleic acid amplification assay for
intraoperative detection of sentinel lymph node macrometastasis in
breast cancer: An updated meta-analysis. Breast. 39:39–45.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chaudhry A, Williams S, Cook J, Jenkins M,
Sohail M, Calder C, Winters ZE and Rayter Z: The real-time
intra-operative evaluation of sentinel lymph nodes in breast cancer
patients using One Step Nucleic Acid Amplification (OSNA) and
implications for clinical decision-making. Eur J Surg Oncol.
40:150–157. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Mansel RE, Fallowfield L, Kissin M, Goyal
A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny
I, et al: Randomized multicenter trial of sentinel node biopsy
versus standard axillary treatment in operable breast cancer: The
ALMANAC Trial. J Natl Cancer Inst. 98:599–609. 2006.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tjan-Heijnen VC, Pepels MJ, de Boer M,
Borm GF, van Dijck JA, van Deurzen CH, Adang EM, Menke-Pluymers MB,
van Diest PJ and Bult P: Impact of omission of completion axillary
lymph node dissection (cALND) or axillary radiotherapy (ax RT) in
breast cancer patients with micrometastases (pN1mi) or isolated
tumor cells (pN0(i+)) in the sentinel lymph node (SN): Results from
the MIRROR study. J Clin Oncol. 27 (Suppl 15):CRA506. 2009.
|
|
28
|
Pepels MJ, de Boer M, Bult P, van Dijck
JA, van Deurzen CH, Menke-Pluymers MB, van Diest PJ, Borm GF and
Tjan-Heijnen VC: Regional recurrence in breast cancer patients with
sentinel node micrometastases and isolated tumor cells. Ann Surg.
255:116–121. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang T-W, Kuo KN, Chen K-H, Chen C, Hou
WH, Lee WH, Chao TY, Tsai JT, Su CM, Huang MT, et al:
Recommendation for axillary lymph node dissection in women with
early breast cancer and sentinel node metastasis: A systematic
review and meta-analysis of randomized controlled trials using the
GRADE system. Int J Surg. 34:73–80. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Houvenaeghel G, Cohen M, Raro P, De Troyer
J, de Lara CT, Gimbergues P, Gauthier T, Faure-Virelizier C,
Vaini-Cowen V, Lantheaume S, et al: Others investigators (SERC
trial group): Overview of the pathological results and treatment
characteristics in the first 1000 patients randomized in the SERC
trial: Axillary dissection versus no axillary dissection in
patients with involved sentinel node. BMC Cancer.
18(1153)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Dauplat MM, E. Barranger E, Classe JM,
Toledano A and Houvenaeghel G: L'exploration et le traitement de la
région axillaire des tumeurs infiltrantes du sein. Oncologie.
15:589–592. 2013.
|
|
32
|
Veronesi U, Paganelli G, Galimberti V,
Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG,
Luini A, et al: Sentinel-node biopsy to avoid axillary dissection
in breast cancer with clinically negative lymph-nodes. Lancet.
349:1864–1867. 1997.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Horimoto Y, Tanabe M, Kazuno S, Miura Y,
Mogushi K, Sonoue H, Arakawa A, Kajino K, Kobayashi T and Saito M:
Elucidation of inhibitory effects on metastatic sentinel lymph
nodes of breast cancer during One-Step Nucleic Acid Amplification.
Sci Rep. 8(7563)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shimazu K, Sato N, Ogiya A, Sota Y,
Yotsumoto D, Ishikawa T, Nakamura S, Kinoshita T, Tsuda H, Ohi Y,
et al: Intraoperative nomograms, based on one-step nucleic acid
amplification, for prediction of non-sentinel node metastasis and
four or more axillary node metastases in breast cancer patients
with sentinel node metastasis. Ann Surg Oncol. 25:2603–2611.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bizzarri N, Pedone Anchora L, Zannoni GF,
Santoro A, Valente M, Inzani F, Gallotta V, Conte C, Chiantera V,
Fanfani F, et al: Role of one-step nucleic acid amplification
(OSNA) to detect sentinel lymph node low-volume metastasis in
early-stage cervical cancer. Int J Gynecol Cancer. 30:364–371.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shimazu K, Miyake T, Okuno J, Naoi Y,
Tanei T, Shimoda M, Kagara N, Kim SJ and Noguchi S: One-step
Nucleic Acid Amplification can identify sentinel node-negative
breast cancer patients with excellent prognosis. Anticancer Res.
39:1447–1454. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Peg V, Espinosa-Bravo M, Vieites B,
Vilardell F, Antúnez JR, de Salas MS, Delgado-Sánchez JJ, Pinto W,
Gozalbo F, Petit A, et al: Intraoperative molecular analysis of
total tumor load in sentinel lymph node: A new predictor of
axillary status in early breast cancer patients. Breast Cancer Res
Treat. 139:87–93. 2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Deambrogio C, Castellano I, Paganotti A,
Zorini EO, Corsi F, Bussone R, Franchini R, Antona J, Miglio U,
Sapino A, et al: A new clinical cut-off of cytokeratin 19 mRNA copy
number in sentinel lymph node better identifies patients eligible
for axillary lymph node dissection in breast cancer. J Clin Pathol.
67:702–706. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Heilmann T, Mathiak M, Hofmann J,
Mundhenke C, van Mackelenbergh M, Alkatout I, Wenners A,
Eckmann-Scholz C and Schem C: Intra-operative use of one-step
nucleic acid amplification (OSNA) for detection of the tumor load
of sentinel lymph nodes in breast cancer patients. J Cancer Res
Clin Oncol. 139:1649–1655. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nabais C, Figueiredo J, Lopes P, Martins M
and Araújo A: Total tumor load assessed by one-step nucleic acid
amplification assay as an intraoperative predictor for non-sentinel
lymph node metastasis in breast cancer. Breast. 32:33–36.
2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Banerjee SM, Michalopoulos NV, Williams
NR, Davidson T, El Sheikh S, McDermott N, Tran-Dang MA, Davison S
and Keshtgar MR: Detailed evaluation of one step nucleic acid
(OSNA) molecular assay for intra-operative diagnosis of sentinel
lymph node metastasis and prediction of non-sentinel nodal
involvement: Experience from a London teaching hospital. Breast.
23:378–384. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Espinosa-Bravo M, Sansano I, Pérez-Hoyos
S, Ramos M, Sancho M, Xercavins J, Rubio IT and Peg V: Prediction
of non-sentinel lymph node metastasis in early breast cancer by
assessing total tumoral load in the sentinel lymph node by
molecular assay. Eur J Surg Oncol. 39:766–773. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Buglioni S, Di Filippo F, Terrenato I,
Casini B, Gallo E, Marandino F, Maini CL, Pasqualoni R, Botti C, Di
Filippo S, et al: Quantitative molecular analysis of sentinel lymph
node may be predictive of axillary node status in breast cancer
classified by molecular subtypes. PLoS One.
8(e58823)2013.PubMed/NCBI View Article : Google Scholar
|
